9.25
price up icon6.08%   0.53
after-market After Hours: 9.27 0.02 +0.22%
loading

Bridgebio Oncology Therapeutics Inc Stock (BBOT) Forecast

The Bridgebio Oncology Therapeutics Inc (BBOT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $9.25. The highest analyst price target is $0.00, and the lowest is $0.00.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BBOT Price Target
Average 0.00 (-100.00% Downside)
loading

Is Bridgebio Oncology Therapeutics Inc (BBOT) A Buy Now?

Oscillators
Name Value Action
RSI(14) 43.60 Neutral
STOCH(9,6) 18.30 Buy
STOCHRSI(14) 74.12 Neutral
MACD(12,26) -0.5149 Sell
ADX(14) 16.41 Neutral
William %R -72.54 Neutral
CCI(14) -31.31 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
9.0195
Buy
9.1417
Buy
MA20
9.5633
Sell
9.5202
Sell
MA50
10.65
Sell
10.36
Sell
MA100
11.51
Sell
10.83
Sell
MA200
8.6896
Buy
0.00
Buy
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, BBOT could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 7 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on BBOT, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 43.6 indicates that BBOT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 18.3 indicates that BBOT is oversold. This indicates that BBOT price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 74.12 indicates that BBOT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 16.41 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -31.31 indicates that BBOT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Bridgebio Oncology Therapeutics Inc Stock (BBOT) Year by Year Forecast

$27.36
price up icon 1.82%
$47.03
price up icon 3.20%
$53.54
price up icon 4.29%
$88.77
price up icon 2.26%
ONC ONC
$283.45
price up icon 2.81%
$148.31
price up icon 6.59%
Cap:     |  Volume (24h):